Alia Bhatt's Alpha fee spotlights Bollywood pay gap

Bollywood’s July bulletin reads less like gossip and more like a balance sheet with drama attached.

One headline has Alia Bhatt drawing a reported Rs 25 crore for Alpha, while Sharvari is said to be at Rs 3 crore. Another has Priyadarshan distancing himself from Hera Pheri 3. Ranveer Singh, meanwhile, is preparing a zombie thriller.

Put together, these are not stray filmi updates. They show an industry trying to price stars, protect old franchises, and build fresh bets at the same time.

Alpha puts pay gaps in focus

Alpha has already become a talking point because of its reported fee split. Alia Bhatt is said to be earning Rs 25 crore for the film. Sharvari’s fee is pegged far lower, at Rs 3 crore.

That gap will surprise nobody inside the film business. Still, the number makes the hierarchy very visible. Bollywood pays for opening value, brand trust, and proven reach.

Alia brings a track record across theatrical films, streaming attention, and advertising power. For a producer, that matters before the first poster drops.

Sharvari, on the other hand, is still being positioned. The lower fee reflects where she stands in the market today. It does not close the door on growth. It simply shows how slowly Hindi cinema raises younger female stars into the top pay bracket.

For viewers, this may look unfair. For studios, it is a risk calculation. They often pay one star for certainty and another for future upside.

Hera Pheri 3 faces fresh doubt

The uncertainty around Hera Pheri 3 is more worrying for trade watchers. Priyadarshan has said he has no connection with the film, and its future looks unclear.

That matters because Hera Pheri is not just another comedy title. It carries memory. For many Indian families, the first two films live on through TV reruns, memes, and everyday one-liners.

But nostalgia can be a tricky asset. It brings a ready audience, but it also brings heavy expectations. One wrong creative call can annoy the same fans who made the brand valuable.

Priyadarshan’s distance from the project will raise questions about tone. The original humour worked because it felt rooted, chaotic, and oddly believable. Recreating that rhythm after so many years is not easy.

Franchise cinema in India now faces a basic test. Can producers revive old hits without treating them like automatic cash machines? Hera Pheri 3 may become a case study in that.

Ranveer Singh moves toward horror

Ranveer Singh is expected to begin shooting Pralay in September. The film is being described as a zombie thriller.

That choice says something about where Hindi cinema is heading. Stars are no longer sticking only to romance, action, or patriotic dramas. They are testing genres that once sat at the edge of the market.

A zombie thriller needs scale, pace, and technical polish. If the film aims for a theatrical audience, it must give viewers something they cannot get casually on streaming.

For Ranveer, the move also carries strategy. A genre film can reset audience perception faster than a safer project. It gives an actor a new visual world and a sharper campaign.

But the risk is also clear. Indian audiences accept horror and thrillers when emotion stays strong. Pure spectacle rarely travels far unless the story lands.

Big names strengthen new slates

The October shooting plan for Nagarwala, featuring John Abraham and Kay Kay Menon, also points to a steady appetite for serious, male-led dramas.

John brings action credibility and a familiar screen presence. Kay Kay Menon brings the kind of gravitas that streaming audiences have rewarded for years.

That mix can work well if the writing is tight. Indian viewers now spot lazy thrillers quickly. They have watched too many crime dramas to forgive weak plotting.

Another update has Alia Bhatt linked to a mysterious role in Kalki 2, with a five-day Hyderabad schedule reportedly completed. That is the kind of casting move that can expand curiosity around a sequel.

Kalki already sits in the big-canvas zone of Indian cinema. Adding a major Hindi star helps widen the conversation beyond language markets. It also shows how pan-India projects now treat casting as market design.

These films are not only about who acts in them. They are about who brings which audience into the theatre.

Global attention, local stakes

S S Rajamouli’s cinema continues to draw attention beyond India. Oscar-winning filmmaker Costa-Gavras reportedly watched two of Rajamouli’s films and attended a masterclass.

That kind of recognition matters, though it should not be overread. Indian films do not need Western approval to prove their worth. But global curiosity can open doors for distribution, festival interest, and talent movement.

Rajamouli has shown that Indian scale can travel when the emotion is direct. That lesson is now shaping how other producers think.

Still, the bigger question remains local. Can Indian studios make films that feel large without losing the viewer sitting in Jaipur, Surat, Lucknow, or Nagpur?

That viewer does not care about trade strategy in the abstract. They care whether the ticket feels worth the money.

For Bollywood, the message from this crowded news cycle is simple. Stars still matter. Franchises still tempt producers. Fresh genres are becoming more attractive. But audiences have become sharper and less forgiving.

The next few months will show which bets have real muscle. A big fee, an old title, or a famous cast can start the conversation. Only a good film can finish it.